Lanean...

New antiviral therapies for chronic hepatitis C

Chronic hepatitis C is an important health issue worldwide. The current standard therapy is based on a combination of pegylated-interferon (pegIFN) and ribavirin (RBV), but this treatment leads to only ~50% sustained virological response (SVR) in patients with HCV genotype 1 and high viral loads, wh...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kanda, Tatsuo, Imazeki, Fumio, Yokosuka, Osamu
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer-Verlag 2010
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2940000/
https://ncbi.nlm.nih.gov/pubmed/21063477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12072-010-9193-3
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!